EX-FILING FEES 4 d270841dexfilingfees.htm EX-FILING FEES EX-FILING FEES

Exhibit 107

Calculation of Filing Fee Tables

Form S-3

(Form Type)

Deciphera Pharmaceuticals, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

 

                         
    

Security

Type

 

  

Security

Class

Title

 

  

Fee

Calculation

or Carry

Forward

Rule

 

  

Amount

Registered (1)

 

  

Proposed

Maximum

Offering

Price Per

Unit (2)

 

  

Maximum

Aggregate

Offering

Price

 

  

Fee

Rate

 

  

Amount of

Registration

Fee

 

  

Carry

Forward

Form

Type

 

  

Carry

Forward

File

Number

 

  

Carry

Forward

Initial

effective

date

 

  

 

Filing Fee

Previously

Paid In

Connection

with Unsold

Securities to
be Carried

Forward

 

 

Newly Registered Securities

 

                     
   

Primary Offering of Securities:

 

                    
                         

Fees to Be

Paid

 

  

Equity

 

  

Common Stock, par value $0.01 per share (3)

 

  

457(r)

 

  

$ —  

 

  

$ —  

 

  

$ —  

 

  

—  

 

  

$ —  

 

          
                         

Fees to Be

Paid

 

  

Equity

 

  

Preferred Stock, par value $0.01 per share (4)

 

  

457(r)

 

  

—  

 

  

—  

 

  

—  

 

  

—  

 

  

—  

 

          
                         

Fees to Be

Paid

 

  

Debt

 

  

Debt Securities (5)

 

  

457(r)

 

  

—  

 

  

—  

 

  

—  

 

  

—  

 

  

—  

 

          
                         

Fees to Be

Paid

 

  

Equity

 

  

Warrants (6)

 

  

457(r)

 

  

—  

 

  

—  

 

  

—  

 

  

—  

 

  

—  

 

          
                         

Fees to Be

Paid

 

  

Equity

 

  

Units (7)

 

  

457(r)

 

  

—  

 

  

—  

 

  

—  

 

  

—  

 

  

—  

 

          
                         

Fees to Be

Paid

 

  

Unallocated

(Universal) Shelf

 

  

(1)

 

  

457(o)

 

  

$150,000,000

 

  

—  

 

  

$150,000,000

 

  

0.0000927

 

  

$13,905

 

          
                     
   

Primary Offering of Common Stock:

 

                    
                         

Fees to Be

Paid

 

  

Equity

 

  

Common Stock, par value $0.01 per share

 

  

457(o)

 

  

$150,000,000

 

  

N/A

 

  

$150,000,000

 

  

0.0000927

 

  

$13,905

 

          
                     

Fees to Be

Paid

 

  

Total Registration Fee:

 

  

$300,000,000

 

  

N/A

 

  

$300,000,000

 

  

—  

 

  

$27,810

 

          
 

Carry Forward Securities

 

                         

Carry

Forward

Securities

 

  

Equity

 

  

Common Stock, par value $0.01 per share

 

  

457(b)

 

  

$172,455,846 (8)

 

  

N/A

 

  

$172,455,846

 

      

424(b)(5)

 

  

333-236389

 

  

August 4, 2020

 

  

$22,384

 

                   
   

Total Offering Amounts 

 

    

$300,000,000

 

    

$27,810

 

          
                   
   

Total Fees Previously Paid 

 

        

—  

 

          
                   
   

Total Fee Offsets 

 

        

$22,384

 

          
                   
   

Net Fee Due 

 

              

$5,426

 

                

(1)

The amount to be registered consists of up to $300,000,000 of an indeterminate amount of common stock, preferred stock, debt securities, warrants and/or units. There is also being registered hereunder such currently indeterminate number of (i) shares of common stock or other securities of the registrant as may be issued upon conversion of, or in exchange for, convertible or exchangeable debt securities and/or preferred stock registered hereby, or (ii) shares of preferred stock, common stock, debt securities or units as may be issued upon exercise of warrants registered hereby, as the case may be, including under any applicable antidilution provisions. Any securities registered hereunder may be sold separately or together with other securities registered hereunder.

(2)

The proposed maximum offering price per security will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of security pursuant to General Instruction II.D. of Form S-3 under the Securities Act.

(3)

Including such indeterminate amount of common stock as may be issued from time to time at indeterminate prices or upon conversion of debt securities and/or preferred stock registered hereby, or upon exercise of warrants registered hereby, as the case may be.

(4)

Including such indeterminate amount of preferred stock as may be issued from time to time at indeterminate prices or upon conversion of debt securities and/or preferred stock registered hereby, or upon exercise of warrants registered hereby, as the case may be.

(5)

Including such indeterminate principal amount of debt securities as may be issued from time to time at indeterminate prices or upon exercise of warrants registered hereby, as the case may be.

(6)

Warrants may be sold separately or together with any of the securities registered hereby and may be exercisable for shares of common stock or preferred stock registered hereby. Because the warrants will provide a right only to purchase such securities offered hereunder, no additional registration fee is required.

(7)

Each unit will be issued under a unit agreement and will represent an interest in two or more securities registered pursuant to this registration statement, which may or may not be separable from one another. Because the units will provide a right only to purchase such securities offered hereunder, no additional registration fee is required.

(8)

The registrant previously paid a fee of $25,960 related to $200,000,000 of the registrant’s shares of common stock that may be issued and sold under a certain sales agreement with Jefferies LLC pursuant to a prospectus supplement filed by the Registrant on August 4, 2020. Of such shares of common stock, $172,455,846 remain unsold, and the registration fee in the amount of $22,384 related thereto is applied to the registrant’s total registration fee. Accordingly, the registrant is paying the registration fee due less the $22,384 that was previously paid, or $5,426.

(9)

Pursuant to 415(a)(6) under the Securities Act, the securities registered pursuant to this Registration Statement include unsold securities previously registered by the Registrant on the Registrant’s Automatic Shelf Registration Statement on Form S-3 (File No. 333-236389), originally filed on February 12, 2020 (the “Prior Registration Statement”) and the prospectus supplement filed by the Registrant on August 4, 2020 (the “Prospectus Supplement”). The Prior Registration Statement and Prospectus Supplement registered the offer and sale of up to $200,000,000 in shares of the Registrant’s common stock, $172,455,846 of which remains unsold as the date of filing of this Amendment No. 1 to this Registration Statement. The Registrant has determined to include in this Registration Statement unsold securities under the Prior Registration Statement and Prospectus Supplement having an aggregate offering price of $172,455,846 (the “Unsold Shelf Securities”). Pursuant to Rule 457(b) under the Securities Act, the filing fee of $22,384 relating to the Unsold Shelf Securities under the Prior Registration Statement, which was paid under the Prior Registration Statement, will continue to be applied to the Unsold Shelf Securities registered pursuant to this Registration Statement.

Table 2: Fee Offset Claims and Sources

 

    

Registrant

or Filer

Name

 

  

Form

or

Filing

Type

 

  

File

Number

 

  

Initial

Filing

Date

 

  

Filing

Date

 

  

Fee Offset

Claimed

 

  

Security

Type

Associated

with Fee

Offset

Claimed

 

  

Security

Title

Associated

with Fee

Offset

Claimed

 

  

Unsold

Securities

Associated

with Fee

Offset

Claimed

 

  

 

Unsold

Aggregate

Offering

Amount

Associated

with Fee

Offset

Claimed

 

  

Fee Paid

with Fee

Offset

Source

 

Rule 457(b) and 0-11(a)(2)

 

Fee Offset

Claims

 

      

—  

 

  

—  

 

  

—  

 

      

—  

 

                    

Fee Offset

Sources

 

  

Deciphera Pharmaceuticals, Inc.

 

  

424(b)(5)

 

  

333-236389

 

  

August 4, 2020

 

  

August 4, 2020

 

  

$22,384

 

  

Equity

 

  

Common Stock, par value $0.01 per

 

  

N/A

 

  

$172,455,846

 

  

$25,960

 

Rule 457(p)

 

Fee Offset

 

  

—  

 

  

—  

 

  

—  

 

  

—  

 

      

—  

 

  

—  

 

  

—  

 

  

—  

 

  

—  

 

    

Claims

 

  

—  

 

  

—

 

  

—  

 

      

—  

 

                      

—